Patent · US Active

Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one

US10730879B2 · kind B2 · utility

2Cited by

63References

4Claims

0Family size

Assignee

Gilead Calistoga LLC · US

Inventors

Ernest A. Carra · Foster City, US
Michael J. Gerber · Oakland, US
Bing Shi · Redwood City, US
Keiko Sujino · Edmonton, CA
Duong Tran · Edmonton, CA
Fang Wang · Foster City, US
Jerry Evarts · Redmond, US

Key dates

Filing date	Sep 6, 2016
Grant date	Aug 4, 2020
Priority date	—
Expiry date	Sep 6, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Polymorphs of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one, compositions thereof, methods for their preparation, and methods for their use are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.